Intrapericardial Delivery of APA-Microcapsules as Promising Stem Cell Therapy Carriers in an Experimental Acute Myocardial Infarction Model
The administration of cardiosphere-derived cells (CDCs) after acute myocardial infarction (AMI) is very promising. CDC encapsulation in alginate-poly-<span style="font-variant: small-caps;">l</span>-lysine-alginate (APA) could increase cell survival and adherence. The intraperi...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3e561752daf44aaa95fd92ae106f53c2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3e561752daf44aaa95fd92ae106f53c2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3e561752daf44aaa95fd92ae106f53c22021-11-25T18:40:55ZIntrapericardial Delivery of APA-Microcapsules as Promising Stem Cell Therapy Carriers in an Experimental Acute Myocardial Infarction Model10.3390/pharmaceutics131118241999-4923https://doaj.org/article/3e561752daf44aaa95fd92ae106f53c22021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4923/13/11/1824https://doaj.org/toc/1999-4923The administration of cardiosphere-derived cells (CDCs) after acute myocardial infarction (AMI) is very promising. CDC encapsulation in alginate-poly-<span style="font-variant: small-caps;">l</span>-lysine-alginate (APA) could increase cell survival and adherence. The intrapericardial (IP) approach potentially achieves high concentrations of the therapeutic agent in the infarcted area. We aimed to evaluate IP therapy using a saline vehicle as a control (CON), a dose of 30 × 10<sup>6</sup> CDCs (CDCs) or APA microcapsules containing 30 × 10<sup>6</sup> CDCs (APA-CDCs) at 72 h in a porcine AMI model. Magnetic resonance imaging (MRI) was used to determine the left ventricular ejection fraction (LVEF), infarct size (IS), and indexed end diastolic and systolic volumes (EDVi; ESVi) pre- and 10 weeks post-injection. Programmed electrical stimulation (PES) was performed to test arrhythmia inducibility before euthanasia. Histopathological analysis was carried out afterwards. The IP infusion was successful in all animals. At 10 weeks, MRI revealed significantly higher LVEF in the APA-CDC group compared with CON. No significant differences were observed among groups in IS, EDVi, ESVi, PES and histopathological analyses. In conclusion, the IP injection of CDCs (microencapsulated or not) was feasible and safe 72 h post-AMI in the porcine model. Moreover, CDCs APA encapsulation could have a beneficial effect on cardiac function, reflected by a higher LVEF at 10 weeks.Claudia Báez-DíazVirginia Blanco-BlázquezFrancisco Miguel Sánchez-MargalloEsther LópezHelena MartínAlbert Espona-NogueraJavier G. CasadoJesús CirizaJosé Luis PedrazVerónica CrisóstomoMDPI AGarticleCDCsAMIintrapericardialmicrocapsulesAPAswinePharmacy and materia medicaRS1-441ENPharmaceutics, Vol 13, Iss 1824, p 1824 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
CDCs AMI intrapericardial microcapsules APA swine Pharmacy and materia medica RS1-441 |
spellingShingle |
CDCs AMI intrapericardial microcapsules APA swine Pharmacy and materia medica RS1-441 Claudia Báez-Díaz Virginia Blanco-Blázquez Francisco Miguel Sánchez-Margallo Esther López Helena Martín Albert Espona-Noguera Javier G. Casado Jesús Ciriza José Luis Pedraz Verónica Crisóstomo Intrapericardial Delivery of APA-Microcapsules as Promising Stem Cell Therapy Carriers in an Experimental Acute Myocardial Infarction Model |
description |
The administration of cardiosphere-derived cells (CDCs) after acute myocardial infarction (AMI) is very promising. CDC encapsulation in alginate-poly-<span style="font-variant: small-caps;">l</span>-lysine-alginate (APA) could increase cell survival and adherence. The intrapericardial (IP) approach potentially achieves high concentrations of the therapeutic agent in the infarcted area. We aimed to evaluate IP therapy using a saline vehicle as a control (CON), a dose of 30 × 10<sup>6</sup> CDCs (CDCs) or APA microcapsules containing 30 × 10<sup>6</sup> CDCs (APA-CDCs) at 72 h in a porcine AMI model. Magnetic resonance imaging (MRI) was used to determine the left ventricular ejection fraction (LVEF), infarct size (IS), and indexed end diastolic and systolic volumes (EDVi; ESVi) pre- and 10 weeks post-injection. Programmed electrical stimulation (PES) was performed to test arrhythmia inducibility before euthanasia. Histopathological analysis was carried out afterwards. The IP infusion was successful in all animals. At 10 weeks, MRI revealed significantly higher LVEF in the APA-CDC group compared with CON. No significant differences were observed among groups in IS, EDVi, ESVi, PES and histopathological analyses. In conclusion, the IP injection of CDCs (microencapsulated or not) was feasible and safe 72 h post-AMI in the porcine model. Moreover, CDCs APA encapsulation could have a beneficial effect on cardiac function, reflected by a higher LVEF at 10 weeks. |
format |
article |
author |
Claudia Báez-Díaz Virginia Blanco-Blázquez Francisco Miguel Sánchez-Margallo Esther López Helena Martín Albert Espona-Noguera Javier G. Casado Jesús Ciriza José Luis Pedraz Verónica Crisóstomo |
author_facet |
Claudia Báez-Díaz Virginia Blanco-Blázquez Francisco Miguel Sánchez-Margallo Esther López Helena Martín Albert Espona-Noguera Javier G. Casado Jesús Ciriza José Luis Pedraz Verónica Crisóstomo |
author_sort |
Claudia Báez-Díaz |
title |
Intrapericardial Delivery of APA-Microcapsules as Promising Stem Cell Therapy Carriers in an Experimental Acute Myocardial Infarction Model |
title_short |
Intrapericardial Delivery of APA-Microcapsules as Promising Stem Cell Therapy Carriers in an Experimental Acute Myocardial Infarction Model |
title_full |
Intrapericardial Delivery of APA-Microcapsules as Promising Stem Cell Therapy Carriers in an Experimental Acute Myocardial Infarction Model |
title_fullStr |
Intrapericardial Delivery of APA-Microcapsules as Promising Stem Cell Therapy Carriers in an Experimental Acute Myocardial Infarction Model |
title_full_unstemmed |
Intrapericardial Delivery of APA-Microcapsules as Promising Stem Cell Therapy Carriers in an Experimental Acute Myocardial Infarction Model |
title_sort |
intrapericardial delivery of apa-microcapsules as promising stem cell therapy carriers in an experimental acute myocardial infarction model |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/3e561752daf44aaa95fd92ae106f53c2 |
work_keys_str_mv |
AT claudiabaezdiaz intrapericardialdeliveryofapamicrocapsulesaspromisingstemcelltherapycarriersinanexperimentalacutemyocardialinfarctionmodel AT virginiablancoblazquez intrapericardialdeliveryofapamicrocapsulesaspromisingstemcelltherapycarriersinanexperimentalacutemyocardialinfarctionmodel AT franciscomiguelsanchezmargallo intrapericardialdeliveryofapamicrocapsulesaspromisingstemcelltherapycarriersinanexperimentalacutemyocardialinfarctionmodel AT estherlopez intrapericardialdeliveryofapamicrocapsulesaspromisingstemcelltherapycarriersinanexperimentalacutemyocardialinfarctionmodel AT helenamartin intrapericardialdeliveryofapamicrocapsulesaspromisingstemcelltherapycarriersinanexperimentalacutemyocardialinfarctionmodel AT albertesponanoguera intrapericardialdeliveryofapamicrocapsulesaspromisingstemcelltherapycarriersinanexperimentalacutemyocardialinfarctionmodel AT javiergcasado intrapericardialdeliveryofapamicrocapsulesaspromisingstemcelltherapycarriersinanexperimentalacutemyocardialinfarctionmodel AT jesusciriza intrapericardialdeliveryofapamicrocapsulesaspromisingstemcelltherapycarriersinanexperimentalacutemyocardialinfarctionmodel AT joseluispedraz intrapericardialdeliveryofapamicrocapsulesaspromisingstemcelltherapycarriersinanexperimentalacutemyocardialinfarctionmodel AT veronicacrisostomo intrapericardialdeliveryofapamicrocapsulesaspromisingstemcelltherapycarriersinanexperimentalacutemyocardialinfarctionmodel |
_version_ |
1718410827469422592 |